SLF Operating Cash Flow (Statement)

Sun Life Financial Inc. Common Stock · Operating Cash Flow (Statement)

SLF logo

SLF Operating Cash Flow (Statement)

Latest reported$10.76B CAD
SLF TTM Cash from Operations · CAD ($2.66B → $10.76B)
High-resolution chart · PNG

SLF operating cash flow (statement) history

Trailing twelve months (TTM) · CAD. Each value covers four complete reported quarters.

Sun Life Financial Inc. Common Stock Operating Cash Flow (Statement) — Trailing twelve months (TTM) (CAD)
Period endingOperating Cash Flow (Statement) (CAD)
10,755,304,524
11,439,304,524
6,925,654,771
2,210,000,000
4,270,000,000
5,166,685,400
6,058,043,400
9,797,244,900
8,360,689,900
8,013,626,100
7,766,755,099
5,667,013,999
6,610,171,599
6,052,549,399
5,640,612,000
5,868,473,200
4,849,605,000
6,309,079,394
5,856,230,395
6,361,995,137
7,141,466,426
7,840,800,267
9,354,330,213
8,901,728,929
6,587,523,240
5,537,715,605
3,399,485,058
2,750,000,000
3,675,000,000
2,177,000,000
3,834,000,000
2,601,000,000
2,113,000,000
3,032,000,000
1,984,000,000
2,711,000,000
2,721,000,000
2,729,000,000
3,668,000,000
4,027,000,000
4,652,000,000
3,892,000,000
4,461,000,000
2,661,000,000
2,354,000,000
2,527,000,000
1,804,000,000
1,755,000,000
1,412,000,000
-178,000,000
627,000,000
1,050,000,000
-45,000,000
2,466,000,000
742,000,000
961,000,000
1,013,000,000
1,430,000,000
2,714,000,000
3,402,000,000
4,157,000,000
3,270,000,000
3,427,000,000
3,013,000,000
3,620,000,000
3,539,000,000
3,548,000,000
2,564,000,000
2,756,000,000
2,242,102,600
1,737,000,000
2,391,603,600
2,030,793,750
1,191,058,700
1,042,000,000
1,558,799,700
2,738,620,350
3,647,221,500
4,469,000,000
4,043,446,100
2,118,595,500
2,555,375,300
2,481,000,000
2,961,811,300
3,616,305,900
3,967,357,650
3,230,000,000
2,701,689,750
1,943,539,500
970,967,100
2,972,000,000
2,686,356,950
4,740,135,800
5,168,176,350
4,313,000,000
4,920,286,000
3,470,290,000
3,165,391,800
2,068,000,000
1,779,019,970
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.